Literature DB >> 29032500

When antibiotic treatment fails.

Matteo Bassetti1,2, Josè Garnacho Montero3, José Artur Paiva4,5.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29032500     DOI： 10.1007/s00134-017-4962-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  11 in total

1.  De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.

Authors:  J Garnacho-Montero; A Gutiérrez-Pizarraya; A Escoresca-Ortega; Y Corcia-Palomo; Esperanza Fernández-Delgado; I Herrera-Melero; C Ortiz-Leyba; J A Márquez-Vácaro
Journal:  Intensive Care Med       Date:  2013-09-12       Impact factor: 17.440

Review 2.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

Review 3.  Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health.

Authors:  George H Talbot; John H Powers; Thomas R Fleming; Judith A Siuciak; John Bradley; Helen Boucher
Journal:  Clin Infect Dis       Date:  2012-06-28       Impact factor: 9.079

4.  Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

Authors:  Jens U Jensen; Lars Hein; Bettina Lundgren; Morten H Bestle; Thomas T Mohr; Mads H Andersen; Klaus J Thornberg; Jesper Løken; Morten Steensen; Zoe Fox; Hamid Tousi; Peter Søe-Jensen; Anne Ø Lauritsen; Ditte Strange; Pernille L Petersen; Nanna Reiter; Søren Hestad; Katrin Thormar; Paul Fjeldborg; Kim M Larsen; Niels E Drenck; Christian Ostergaard; Jesper Kjær; Jesper Grarup; Jens D Lundgren
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

5.  Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome.

Authors:  Carlos M Luna; Daniel Blanzaco; Michael S Niederman; Walter Matarucco; Natalio C Baredes; Pablo Desmery; Fernando Palizas; Guillermo Menga; Fernando Rios; Carlos Apezteguia
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

Review 6.  Early antibiotic treatment failure.

Authors:  Miguel Sánchez García
Journal:  Int J Antimicrob Agents       Date:  2009-08       Impact factor: 5.283

Review 7.  Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Authors:  Matteo Bassetti; Garyphallia Poulakou; Etienne Ruppe; Emilio Bouza; Sebastian J Van Hal; Adrian Brink
Journal:  Intensive Care Med       Date:  2017-07-21       Impact factor: 17.440

8.  Markers of treatment failure in hospitalised community acquired pneumonia.

Authors:  R Menéndez; M Cavalcanti; S Reyes; J Mensa; R Martinez; M A Marcos; X Filella; M Niederman; A Torres
Journal:  Thorax       Date:  2008-02-01       Impact factor: 9.139

9.  Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia.

Authors:  Renato Seligman; Michael Meisner; Thiago C Lisboa; Felipe T Hertz; Tania B Filippin; Jandyra M G Fachel; Paulo J Z Teixeira
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.

Authors:  Jean-François Timsit; Marlieke E A de Kraker; Harriet Sommer; Emmanuel Weiss; Esther Bettiol; Martin Wolkewitz; Stavros Nikolakopoulos; David Wilson; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440
View more
  9 in total

1.  Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis.

Authors:  Shani Feldman; Alessandro Russo; Giancarlo Ceccarelli; Cristian Borrazzo; Chiara Madge; Mario Venditti; Manuela Merli
Journal:  J Clin Exp Hepatol       Date:  2022-04-21

Review 2.  A Review: Antimicrobial Therapy for Human Pythiosis.

Authors:  Sadeep Medhasi; Ariya Chindamporn; Navaporn Worasilchai
Journal:  Antibiotics (Basel)       Date:  2022-03-26

Review 3.  Variation in Antibiotic Treatment Failure Outcome Definitions in Randomised Trials and Observational Studies of Antibiotic Prescribing Strategies: A Systematic Review and Narrative Synthesis.

Authors:  Rebecca Neill; David Gillespie; Haroon Ahmed
Journal:  Antibiotics (Basel)       Date:  2022-05-06

4.  XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.

Authors:  Yuanlin Song; Chen Yao; Yongming Yao; Hui Han; Xiaodong Zhao; Kaijiang Yu; Luyi Liu; Ying Xu; Zhongmin Liu; Qingshan Zhou; Ying Wang; Zhuang Ma; Youguang Zheng; Dawei Wu; Zhongzhi Tang; Minzhou Zhang; Shuming Pan; Yanfen Chai; Yan Song; Jian Zhang; Lei Pan; Yi Liu; He Yu; Xuezhong Yu; Hong Zhang; Xiaoge Wang; Zhaohui Du; Xianyao Wan; Yijun Tang; Yingping Tian; Yimin Zhu; Hongliang Wang; Xiaoyan Yan; Zhi Liu; Boli Zhang; Nanshan Zhong; Hongcai Shang; Chunxue Bai
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

5.  Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study.

Authors:  Young-Jin Choi; Ju-Hee Jeon; Jae-Won Oh
Journal:  Respir Res       Date:  2019-08-23

6.  Evaluation and enhancement of standard equations for renal function estimation in individuals with components of metabolic disease.

Authors:  Luigi Brunetti; Hyunmoon Back; Sijia Yu; Urma Jalil; Leonid Kagan
Journal:  BMC Nephrol       Date:  2021-11-22       Impact factor: 2.388

7.  Evaluation of a New Culture-Based AtbFinder Test-System Employing a Novel Nutrient Medium for the Selection of Optimal Antibiotics for Critically Ill Patients with Polymicrobial Infections within 4 h.

Authors:  George Tetz; Victor Tetz
Journal:  Microorganisms       Date:  2021-05-04

8.  Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.

Authors:  Antoni Torres; Alex Soriano; Simone Rivolo; Edit Remak; Carmen Peral; Michal Kantecki; Wajeeha Ansari; Claudie Charbonneau; Jennifer Hammond; Santiago Grau; Mark Wilcox
Journal:  Clinicoecon Outcomes Res       Date:  2022-03-18

9.  Diagnostic Value of Procalcitonin and C reactive Protein for Infection and Sepsis in Elderly Patients.

Authors:  Çiler Zincircioğlu; Kazim Rollas; Işil Güldoğan; Aykut Saritaş; Hüseyin Özkarakaş; Gürsel Ersan; Nimet Şenoğlu
Journal:  Turk J Med Sci       Date:  2021-08-04       Impact factor: 0.973
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.